GlassScriptPhysician profile
Alexander Azbel
NPI 1134115959
$2,730.61
in general payments reported to CMS, 2019-2025
12 companies · $741 in 2025
The $741 reported for 2025 was more than what 83% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $880 · 2020: $119 · 2021: $121 · 2022: $175 · 2023: $192 · 2024: $503 · 2025: $741.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,436.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,039.30 | 2020-2025 | General - Embolics, Embold Fibered, General - Interventional Oncology |
| Sirtex Medical INC | $444.06 | 2019-2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Penumbra, INC. | $375.00 | 2019 | |
| Stryker Corporation | $174.58 | 2022 | |
| Medtronic, INC. | $151.00 | 2024 | Mvp |
| Terumo Medical Corporation | $125.54 | 2025 | Azur Cx Detachable |
| Ethicon US, LLC | $120.56 | 2021 | |
| Ekos Corporation | $97.21 | 2019 | |
| Siemens Medical Solutions USA, INC. | $87.72 | 2023-2025 | Microthermx Microwave Ablation System, Embozene |
| Medtronic Vascular, INC. | $72.32 | 2019 | |
| Biocompatibles, INC. | $28.03 | 2019 | |
| Bard Peripheral Vascular, INC. | $15.29 | 2023 | Rotarexs 6 F X 135 Cm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Azbel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.